According to BioIntel360, Asia Pacific cell and gene therapy market size is expected to record a CAGR of 20.7% during 2023-2027 to reach US$12,477.2 million by 2027, increasing from US$4,871.2 million...
According to BioIntel360, Asia Pacific cell and gene therapy market size is expected to record a CAGR of 20.7% during 2023-2027 to reach US$12,477.2 million by 2027, increasing from US$4,871.2 million in 2023. Over the last five years, the sector has recorded a CAGR of 24.6% to reach US$3,908.8 million in 2022. This offering from BioIntel360 is a bundled offering, combining 5 countries and a key report covering Asia Pacific region. This report provides an in-depth data-centric analysis of the emerging opportunities in cell and gene therapy industry in Asia Pacific region. It covers a detailed view of market size and forecast across various segments such as by different therapy segment, type of therapy, the purpose of manufacturing, type of cell, route of administration, delivery mode, source of cell, source of manufacturing, therapeutic class, technology, end-user and by product. This title from BioIntel360 is a bundled offering, combining the following 6 reports, covering 215+ tables and 294+ figures: Country Report 1 - Asia Pacific Cell & Gene Therapy Business and Investment Opportunities Databook – Q2 2023 Update Country Report 2 - China Cell & Gene Therapy Business and Investment Opportunities Databook – Q2 2023 Update Country Report 3 -Japan Cell & Gene Therapy Business and Investment Opportunities Databook – Q2 2023 Update Country Report 4 -Australia Cell & Gene Therapy Business and Investment Opportunities Databook – Q2 2023 Update Country Report 5 - India Cell & Gene Therapy Business and Investment Opportunities Databook – Q2 2023 Update Country Report 6 - South Korea Cell & Gene Therapy Business and Investment Opportunities Databook – Q2 2023 Update
This report provides an in-depth, data-centric analysis of the Asia Pacific cell and gene therapy market 2018-2027. Below is a summary of key market segments: Cell & Gene Therapy Market Size by Different Therapy Segment, 2018-2027 • Cell and Gene Modified Cell Therapies • Gene Therapy and Genome Therapy • DNA & RNA Therapeutics Cell & Gene Therapy Market Size by Purpose of Manufacturing • Commercial • Clinical Cell & Gene Therapy Market Size by Product • Abecma • Amondys • Breyanzi • Carvykti • Givlaari • Kimmtrak • Kymriah • Leqvio • Luxturna • Onpattro • Oxlumo • Rethymic • Skysona • Stratagraft • Tecartus • Tegsedi • Viltepso • Vyondys • Yescarta • Zolgensma • Zynteglo Cell & Gene Therapy Market Size by Route of Administration • Injectables • Infusions • Bioscaffolds • Topicals Cell & Gene Therapy Market Size by Type of Cell • CAR-T Cell • TCR Cell Cell & Gene Therapy Market Size by Type of Therapy • T-Cell Therapies • NK Cell • Dendritic Cell Therapies • Stem Cell Therapies Cell & Gene Therapy Market Size by Source of Cell • Autologous • Allogenic Cell & Gene Therapy Market Size by Delivery Mode • In vivo • ex-vivo Cell & Gene Therapy Market Size by Source of Manufacturing • In-House • Contract Manufacturing Cell & Gene Therapy Market Size by Therapeutic Class • Oncology • Neurology • Ophthalmology • Musculoskeletal • Others Cell & Gene Therapy Market Size by Technology • Viral Vector Technology • Cell Immortalization Technology • Genome Editing Technology • Others Cell & Gene Therapy Market Size by End User • Pharmaceutical & Biotechnology Companies • Academic & Research Institutes • Hospital & Clinics
• In-depth understanding of cell and gene therapy market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in Asia Pacific. • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry. • Get market share analysis by end users: Get a detailed analysis across different end users such as pharmaceutical, biotechnology companies, academic & research institutes, and by hospitals & clinics within the Asia Pacific.
This title from BioIntel360 is a bundled offering, combining the following 6 reports, covering 215+ tables and 294+ figures: Country Report 1 - Asia Pacific Cell & Gene Therapy Business and Investment Opportunities Databook – Q2 2023 Update Country Report 2 - China Cell & Gene Therapy Business and Investment Opportunities Databook – Q2 2023 Update Country Report 3 -Japan Cell & Gene Therapy Business and Investment Opportunities Databook – Q2 2023 Update Country Report 4 -Australia Cell & Gene Therapy Business and Investment Opportunities Databook – Q2 2023 Update Country Report 5 - India Cell & Gene Therapy Business and Investment Opportunities Databook – Q2 2023 Update Country Report 6 - South Korea Cell & Gene Therapy Business and Investment Opportunities Databook – Q2 2023 Update 1. About this Report 1.1 Research Methodology 1.2 Disclaimer 2 Cell and Gene Therapy Market Size and Forecast, 2018-2027 3 Cell and Gene Therapy Market Share by Different Therapy Segment, 2018-2027 3.1 Market Size by Cell and Gene Modified Cell Therapies, 2018-2027 3.2 Market Size by Gene Therapy and Genome Therapy, 2018-2027 3.3 Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, 2018-2027 4 Cell and Gene Therapy Market Share by Purpose of Manufacturing, 2018-2027 4.1 Cell and Gene Therapy Market Size by Commercial, 2018-2027 4.2 Cell and Gene Therapy Market Size by Clinical, 2018-2027 5 Cell and Gene Therapy Market Share by Product, 2018-2027 6 Cell and Gene Therapy Market Share by Route of Administration, 2018-2027 6.1 Cell and Gene Therapy Market Size by Injectables, 2018-2027 6.2 Cell and Gene Therapy Market Size by Topicals, 2018-2027 6.3 Cell and Gene Therapy Market Size by Infusions, 2018-2027 6.4 Cell and Gene Therapy Market Size by Bioscaffolds, 2018-2027 7 Cell and Gene Therapy Market Share by Type of Diseases, 2018-2027 7.1 Cell and Gene Therapy Market Size by Rare Diseases, 2018-2027 7.2 Cell and Gene Therapy Market Size by Non-Rare Diseases, 2018-2027 8 Cell and Gene Therapy Market Share by Type of Cell, 2018-2027 8.1 Cell and Gene Therapy Market Size by CAR-T Cell, 2018-2027 8.2 Cell and Gene Therapy Market Size by TCR Cell, 2018-2027 9 Cell and Gene Therapy Market Share by Therapy, 2018-2027 9.1 Cell and Gene Therapy Market Size by T-Cell Therapies, 2018-2027 9.2 Cell and Gene Therapy Market Size by NK Cell, 2018-2027 9.3 Cell and Gene Therapy Market Size by Dendritic Cell Therapies, 2018-2027 9.4 Cell and Gene Therapy Market Size by Stem Cell Therapies, 2018-2027 10 Cell and Gene Therapy Market Share by Source of Cell, 2018-2027 10.1 Cell and Gene Therapy Market Size by Autologous, 2018-2027 10.2 Cell and Gene Therapy Market Size by Allogenic, 2018-2027 11 Cell and Gene Therapy Market Share by Delivery Mode, 2018-2027 11.1 Cell and Gene Therapy Market Size by In-vivo, 2018-2027 11.2 Cell and Gene Therapy Market Size by Ex-vivo, 2018-2027 12 Cell and Gene Therapy Market Share by Source of Manufacturing, 2018-2027 12.1 Cell and Gene Therapy Market Size by In-House, 2018-2027 12.2 Cell and Gene Therapy Market Size by Contract Manufacturing, 2018-2027 13 Cell and Gene Therapy Market Share by Therapeutic Class, 2018-2027 13.1 Cell and Gene Therapy Market Size by Oncology, 2018-2027 13.2 Cell and Gene Therapy Market Size by Neurology, 2018-2027 13.3 Cell and Gene Therapy Market Size by Ophthalmology, 2018-2027 13.4 Cell and Gene Therapy Market Size by Musculoskeletal, 2018-2027 13.5 Cell and Gene Therapy Market Size by Others, 2018-2027 14 Cell and Gene Therapy Market Share by Technology, 2018-2027 14.1 Cell and Gene Therapy Market Size by Viral Vector Technology, 2018-2027 14.2 Cell and Gene Therapy Market Size by Cell Immortalization Technology, 2018-2027 14.3 Cell and Gene Therapy Market Size by Genome Editing Technology, 2018-2027 14.4 Cell and Gene Therapy Market Size by Others Technologies, 2018-2027 15 Cell and Gene Therapy Market Share by End User, 2018-2027 15.1 Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, 2018-2027 15.2 Cell and Gene Therapy Market Size by Academic & Research Institutes, 2018-2027 15.3 Cell and Gene Therapy Market Size by Hospital & Clinics, 2018-2027 16 Further Reading 16.1 About BioIntel360 16.2 Related Research 16.3 Consulting
Table 1: Cell and Gene Therapy Market Size by Value (USD MM) 2018-2027 Table 2: Cell and Gene Therapy Market Size by Cell and Gene Modified Cell Therapies, by Value (USD MM), 2018-2027 Table 3: Cell and Gene Therapy Market Size by Gene Therapy and Genome Therapy, by Value (USD MM) 2018-2027 Table 4: Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, by Value (USD MM) 2018-2027 Table 5: Cell and Gene Therapy Market Size by Commercial, by Value (USD MM) 2018-2027 Table 6: Cell and Gene Therapy Market Size by Clinical, by Value (USD MM) 2018-2027 Table 7: Cell and Gene Therapy Market Size by Injectables, by Value (USD MM) 2018-2027 Table 8: Cell and Gene Therapy Market Size by Topicals, by Value (USD MM) 2018-2027 Table 9: Cell and Gene Therapy Market Size by Infusions, by Value (USD MM) 2018-2027 Table 10: Cell and Gene Therapy Market Size by Bio scaffolds, by Value (USD MM) 2018-2027 Table 11: Cell and Gene Therapy Market Size by Rare Diseases, by Value (UDS MM) 2018-2027 Table 12: Cell and Gene Therapy Market Size by Non-Rare Diseases, by Value (UDS MM) 2018-2027 Table 13: Cell and Gene Therapy Market Size by CAR-T Cell, by Value (UDS MM) 2018-2027 Table 14: Cell and Gene Therapy Market Size by TCR Cell, by Value (UDS MM) 2018-2027 Table 15: Cell and Gene Therapy Market Size by T-Cell Therapies, by Value (USD MM), 2018-2027 Table 16: Cell and Gene Therapy Market Size by NK Cell, by Value (USD MM), 2018-2027 Table 17: Cell and Gene Therapy Market Size by Dendritic Cell Therapies, by Value (USD MM), 2018-2027 Table 18: Cell and Gene Therapy Market Size by Stem Cell Therapies, by Value (USD MM), 2018-2027 Table 19: Cell and Gene Therapy Market Size by Autologous (USD MM), 2018-2027 Table 20: Cell and Gene Therapy Market Size by Allogenic (USD MM), 2018-2027 Table 21: Cell and Gene Therapy Market Size by In-vivo, by Value (USD MM), 2018-2027 Table 22: Cell and Gene Therapy Market Size by Ex-vivo, by Value (USD MM), 2018-2027 Table 23: Cell and Gene Therapy Market Size by In-House, by Value (USD MM), 2018-2027 Table 24: Cell and Gene Therapy Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027 Table 25: Cell and Gene Therapy Market Size by Oncology, by Value (USD MM), 2018-2027 Table 26: Cell and Gene Therapy Market Size by Neurology, by Value (USD MM), 2018-2027 Table 27: Cell and Gene Therapy Market Size by Ophthalmology, by Value (USD MM), 2018-2027 Table 28: Cell and Gene Therapy Market Size by Musculoskeletal, by Value (USD MM), 2018-2027 Table 29: Cell and Gene Therapy Market Size by Others, by Value (USD MM), 2018-2027 Table 30: Cell and Gene Therapy Market Size by Viral Vector Technology, by Value (USD MM), 2018-2027 Table 31: Cell and Gene Therapy Market Size by Cell Immortalization Technology, by Value (USD MM), 2018-2027 Table 32: Cell and Gene Therapy Market Size by Genome Editing Technology, by Value (USD MM), 2018-2027 Table 33: Cell and Gene Therapy Market Size by Others Technologies, by Value (USD MM), 2018-2027 Table 34: Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, by Value (USD MM), 2018-2027 Table 35: Cell and Gene Therapy Market Size by Academic & Research Institutes, by Value (USD MM), 2018-2027 Table 36: Cell and Gene Therapy Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027
Figure 1: Cell and Gene Therapy Market Size by Value (USD MM) 2018-2027 Figure 2: Cell and Gene Therapy Market Share by Different Therapy Segment (%), 2018-2027 Figure 3: Cell and Gene Therapy Market Size by Cell and Gene Modified Cell Therapies, by Value (USD MM), 2018-2027 Figure 4: Cell and Gene Therapy Market Size by Gene Therapy and Genome Therapy, by Value (USD MM) 2018-2027 Figure 5: Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, by Value (USD MM) 2018-2027 Figure 6: Cell and Gene Therapy Market Share Purpose of Manufacturing (%), 2018-2027 Figure 7: Cell and Gene Therapy Market Size by Commercial, by Value (USD MM) 2018-2027 Figure 8: Cell and Gene Therapy Market Size, By Clinical, by Value (USD MM) 2018-2027 Figure 9: Cell and Gene Therapy Market Share by Product (%), 2018-2027 Figure 10: Cell and Gene Therapy Market Share by Route of Administration (%), 2018-2027 Figure 11: Cell and Gene Therapy Market Size by Injectables, by Value (USD MM) 2018-2027 Figure 12: Cell and Gene Therapy Market Size by Topicals, by Value (USD MM) 2018-2027 Figure 13: Cell and Gene Therapy Market Size by Infusions, by Value (USD MM) 2018-2027 Figure 14: Cell and Gene Therapy Market Size by Bio scaffolds, by Value (USD MM) 2018-2027 Figure 15: Cell and Gene Therapy Market Share by Type of Diseases (%), 2018-2027 Figure 16: Cell and Gene Therapy Market Share by Rare Diseases, by Value (UDS MM) 2018-2027 Figure 17: Cell and Gene Therapy Market Share by Non-Rare Diseases, by Value (UDS MM) 2018-2027 Figure 18: Cell and Gene Therapy Market Share by Type of Cell (%), 2018-2027 Figure 19: Cell and Gene Therapy Market Share by CAR-T Cell, by Value (UDS MM) 2018-2027 Figure 20: Cell and Gene Therapy Market Share by TCR Cell, by Value (UDS MM) 2018-2027 Figure 21: Cell and Gene Therapy Market Share by Therapy (%), 2018-2027 Figure 22: Cell and Gene Therapy Market Size by T-Cell Therapies, by Value (USD MM), 2018-2027 Figure 23: Cell and Gene Therapy Market Size by NK Cell, by Value (USD MM), 2018-2027 Figure 24: Cell and Gene Therapy Market Size by Dendritic Cell Therapies, by Value (USD MM), 2018-2027 Figure 25: Cell and Gene Therapy Market Size by Stem Cell Therapies, by Value (USD MM), 2018-2027 Figure 26: Cell and Gene Therapy Market Share by Source of Cell (%), 2018-2027 Figure 27: Cell and Gene Therapy Market Size by Autologous (USD MM), 2018-2027 Figure 28: Cell and Gene Therapy Market Size by Allogenic (USD MM), 2018-2027 Figure 29: Cell and Gene Therapy Market Share by Delivery Mode (%), 2018-2027 Figure 30: Cell and Gene Therapy Market Size by In-vivo, by Value (USD MM), 2018-2027 Figure 31: Cell and Gene Therapy Market Size by Ex-vivo, by Value (USD MM), 2018-2027 Figure 32: Cell and Gene Therapy Market Share by Source of Manufacturing (%), 2018-2027 Figure 33: Cell and Gene Therapy Market Size by In-House, by Value (USD MM), 2018-2027 Figure 34: Cell and Gene Therapy Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027 Figure 35: Cell and Gene Therapy Market Share by Therapeutic Class (%), 2018-2027 Figure 36: Cell and Gene Therapy Market Size by Oncology, by Value (USD MM), 2018-2027 Figure 37: Cell and Gene Therapy Market Size by Neurology, by Value (USD MM), 2018-2027 Figure 38: Cell and Gene Therapy Market Size by Ophthalmology, by Value (USD MM), 2018-2027 Figure 39: Cell and Gene Therapy Market Size by Musculoskeletal, by Value (USD MM), 2018-2027 Figure 40: Cell and Gene Therapy Market Size by Others, by Value (USD MM), 2018-2027 Figure 41: Cell and Gene Therapy Market Share by Technology (%), 2018-2027 Figure 42: Cell and Gene Therapy Market Size by Viral Vector Technology, by Value (USD MM), 2018-2027 Figure 43: Cell and Gene Therapy Market Size by Cell Immortalization Technology, by Value (USD MM), 2018-2027 Figure 44: Cell and Gene Therapy Market Size by Genome Editing Technology, by Value (USD MM), 2018-2027 Figure 45: Cell and Gene Therapy Market Size by Others Technologies, by Value (USD MM), 2018-2027 Figure 46: Cell and Gene Therapy Market Share by End User (%), 2018-2027 Figure 47: Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, by Value (USD MM), 2018-2027 Figure 48: Cell and Gene Therapy Market Size by Academic & Research Institutes, by Value (USD MM), 2018-2027 Figure 49: Cell and Gene Therapy Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027
